Trial · NCT00889915
Adverse events44
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 44
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Irritability | Psychiatric disorders | Daytrana (Methylphenidate Transdermal System | 1 | 33 | 9 |
| other | Irritability | Psychiatric disorders | Vyvanse (Lisdexamfetamine Dimesylate) | 5 | 67 | 9 |
| other | Irritability | Psychiatric disorders | Concerta (Osmotic-release Oral System Methylphenidate) | 1 | 53 | 9 |
| other | Irritability | Psychiatric disorders | Adderall (Mixed Amphetamine Salts Extended Release) | 2 | 39 | 9 |
| other | Insomnia | Psychiatric disorders | Daytrana (Methylphenidate Transdermal System | 5 | 33 | 18 |
| other | Insomnia | Psychiatric disorders | Vyvanse (Lisdexamfetamine Dimesylate) | 6 | 67 | 18 |
| other | Insomnia | Psychiatric disorders | Concerta (Osmotic-release Oral System Methylphenidate) | 5 | 53 | 18 |
| other | Insomnia | Psychiatric disorders | Adderall (Mixed Amphetamine Salts Extended Release) | 2 | 39 | 18 |
| other | Angry or hostile mood | Psychiatric disorders | Daytrana (Methylphenidate Transdermal System | 1 | 33 | 9 |
| other | Angry or hostile mood | Psychiatric disorders | Vyvanse (Lisdexamfetamine Dimesylate) | 3 | 67 | 9 |
| other | Angry or hostile mood | Psychiatric disorders | Concerta (Osmotic-release Oral System Methylphenidate) | 2 | 53 | 9 |
| other | Angry or hostile mood | Psychiatric disorders | Adderall (Mixed Amphetamine Salts Extended Release) | 3 | 39 | 9 |
| other | Weight loss | General disorders | Daytrana (Methylphenidate Transdermal System | 2 | 33 | 10 |
| other | Weight loss | General disorders | Vyvanse (Lisdexamfetamine Dimesylate) | 3 | 67 | 10 |
| other | Weight loss | General disorders | Concerta (Osmotic-release Oral System Methylphenidate) | 3 | 53 | 10 |
| other | Weight loss | General disorders | Adderall (Mixed Amphetamine Salts Extended Release) | 2 | 39 | 10 |
| other | Decreased appetite | General disorders | Daytrana (Methylphenidate Transdermal System | 5 | 33 | 25 |
| other | Decreased appetite | General disorders | Vyvanse (Lisdexamfetamine Dimesylate) | 11 | 67 | 25 |
| other | Decreased appetite | General disorders | Concerta (Osmotic-release Oral System Methylphenidate) | 4 | 53 | 25 |
| other | Decreased appetite | General disorders | Adderall (Mixed Amphetamine Salts Extended Release) | 5 | 39 | 25 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00889915/events